CTLA4 and neoplasm: Tregs, recruited by tumor‐derived chemokines, suppress DC immunogenicity through multiple mechanisms, including CTLA‐4‐mediated downregulation of CD80/CD86, induction of IDO expression, and secretion of inhibitory cytokines.